Related Experiment Video
Updated: Jul 18, 2025
The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
Published on: August 5, 2017
Neuroinflammation in fetal alcohol spectrum disorders and related novel therapeutic approaches
Mayra Madeleine Padilla-Valdez1, María Isabel Díaz-Iñiguez1, Daniel Ortuño-Sahagún2
1Departamento de Ciencias Ambientales, Universidad de Guadalajara, Centro Universitario de Ciencias Biológicas y Agropecuarias, Guadalajara 45200, Mexico; Laboratorio de Neuroinmunobiología Molecular, Instituto de Investigación en Ciencias Biomédicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, C.P 44340 Guadalajara, JAL, Mexico.
Insights
Prenatal alcohol exposure (PAE) can cause Fetal Alcohol Spectrum Disorders (FASD) affecting brain development. Neuroinflammation plays a key role, suggesting anti-inflammatory treatments may offer future therapeutic benefits for FASD.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Fetal alcohol spectrum disorders (FASD) result from prenatal alcohol exposure (PAE).
- PAE disrupts brain development, causing cell proliferation issues and malformations.
- Neuroinflammation is increasingly recognized as a significant contributor to PAE-induced neurotoxicity.
Purpose of the Study:
- To review the role of neuroinflammation in FASD.
- To explore the potential of anti-inflammatory drugs and nutraceuticals for FASD treatment.
Main Methods:
- Literature review of studies on PAE, FASD, neuroinflammation, and therapeutic interventions.
- Analysis of existing research on anti-inflammatory agents and nutraceuticals relevant to neurodevelopmental disorders.
Main Results:
- Neuroinflammation is a critical factor in the neurotoxic effects of PAE.
- Anti-inflammatory drugs and certain nutraceuticals show promise in preclinical studies.
- Current FASD diagnosis and treatment often overlook the role of neuroinflammation.
Conclusions:
- Neuroinflammation is a key mechanism underlying FASD pathology.
- Targeting neuroinflammation with anti-inflammatory drugs or nutraceuticals represents a promising therapeutic avenue.
- Further research is needed to translate these findings into clinical practice for FASD management.
Abstract:
Fetal alcohol spectrum disorders (FASD) is an umbrella term to describe the neurological effects of prenatal alcohol exposure (PAE). It has been extensively characterized that PAE causes cell proliferation disruption, heterotopias, and malformations in various brain regions and there is increasing evidence that neuroinflammation is responsible for some of these neurotoxic effects. Despite evidence of its importance, neuroinflammation is not usually considered at diagnosis or treatment for FASD. Here, we discuss the literature regarding anti- inflammatory drugs and nutraceuticals, which hold promise for future therapeutical interventions in these disorders.
